TEVA · Harel Insurance Investments & Financial Services Ltd

Harel Insurance Investments & Financial Services Ltd. filed an amended Schedule 13G disclosing beneficial ownership of 70,418,201 ordinary shares of Teva Pharmaceutical Industries Ltd., representing a 6.0% stake as of September 30, 2026. This is an increase from the prior filing (Harel's previous 13G/A on February 9, 2026, which reported 69,390,266 shares). The filing remains passive, with no intent to influence control.

• Harel Insurance Investments & Financial Services Ltd. reports 70,418,201 ordinary shares (6.0% of Teva's outstanding shares) as of September 30, 2026.
• The stake increased from 69,390,266 shares reported in the prior 13G/A filed February 9, 2026.
• Of the total, 68,375,069 shares are held for public members through managed funds, 1,027,935 shares are in third-party client accounts, and 1,015,197 shares are held for Harel's own account.
• The filing is passive under Rule 13d-1(c); Harel certifies the shares were not acquired to change or influence control.